During September, the registered number of shares and votes in Ascelia Pharma AB (”Ascelia Pharma”) has increased due to the rights issue of units resolved by the Board of Directors on 10 July 2024 and approved by the Extraordinary General Meeting on 14 August 2024. As of 30 September 2024, the total number of shares in Ascelia Pharma amounts to 97,193,153 shares, whereof 96,079,722 are ordinary shares with one vote each and 1,113,431 are series C shares with 1/10 vote each. The total number of votes as of 30 September 2024 amounts to 96,191,065.1.